219 related articles for article (PubMed ID: 34968032)
1. Modulating Angiogenesis by Proteomimetics of Vascular Endothelial Growth Factor.
Abdulkadir S; Li C; Jiang W; Zhao X; Sang P; Wei L; Hu Y; Li Q; Cai J
J Am Chem Soc; 2022 Jan; 144(1):270-281. PubMed ID: 34968032
[TBL] [Abstract][Full Text] [Related]
2. Sulfono-γ-AApeptides as Protein Helical Domain Mimetics to Manipulate the Angiogenesis.
Xue S; Wang L; Cai J
Chembiochem; 2022 Nov; 23(22):e202200298. PubMed ID: 36006398
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
4. Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.
Vicari D; Foy KC; Liotta EM; Kaumaya PT
J Biol Chem; 2011 Apr; 286(15):13612-25. PubMed ID: 21321115
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
6. A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
Assareh E; Mehrnejad F; Mansouri K; Esmaeili Rastaghi AR; Naderi-Manesh H; Asghari SM
Biochem J; 2019 Feb; 476(4):645-663. PubMed ID: 30700502
[TBL] [Abstract][Full Text] [Related]
7. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling.
Chen J; Wang Y; Wang S; Zhao X; Zhao L; Wang Y
J Ethnopharmacol; 2022 Jan; 283():114667. PubMed ID: 34597652
[TBL] [Abstract][Full Text] [Related]
9. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.
Sang P; Zhang M; Shi Y; Li C; Abdulkadir S; Li Q; Ji H; Cai J
Proc Natl Acad Sci U S A; 2019 May; 116(22):10757-10762. PubMed ID: 31088961
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.
Patel NS; Mathura VS; Bachmeier C; Beaulieu-Abdelahad D; Laporte V; Weeks O; Mullan M; Paris D
J Neurochem; 2010 Jan; 112(1):66-76. PubMed ID: 19818105
[TBL] [Abstract][Full Text] [Related]
12. Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site.
Ghavamipour F; Shahangian SS; Sajedi RH; Arab SS; Mansouri K; Aghamaali MR
FEBS J; 2014 Oct; 281(19):4479-94. PubMed ID: 25132001
[TBL] [Abstract][Full Text] [Related]
13. Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling.
Toivanen PI; Nieminen T; Laakkonen JP; Heikura T; Kaikkonen MU; Ylä-Herttuala S
Sci Rep; 2017 Jul; 7(1):5525. PubMed ID: 28717175
[TBL] [Abstract][Full Text] [Related]
14. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
15. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
16. Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.
D'Andrea LD; Iaccarino G; Fattorusso R; Sorriento D; Carannante C; Capasso D; Trimarco B; Pedone C
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14215-20. PubMed ID: 16186493
[TBL] [Abstract][Full Text] [Related]
17. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model.
Park K; Amano H; Ito Y; Kashiwagi S; Yamazaki Y; Takeda A; Shibuya M; Kitasato H; Majima M
Biomed Pharmacother; 2016 Mar; 78():140-149. PubMed ID: 26898435
[TBL] [Abstract][Full Text] [Related]
19. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
20. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies.
Shibuya M
Genes Cancer; 2011 Dec; 2(12):1097-105. PubMed ID: 22866201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
